Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Fly the pride flag—and free the LGBTQ+ community from the oppression of smoking
FreeGuest Editorial

Fly the pride flag—and free the LGBTQ+ community from the oppression of smoking

June 25, 2021
Vol.47 No.25
By Phoenix A. Matthews
The Cancer Letter receives 8 journalism, design awards
EditorialFree

The Cancer Letter receives 8 journalism, design awards

June 18, 2021
Vol.47 No.24
By Paul Goldberg
Precision oncology must evolve to address health disparities
FreeTrials & Tribulations

Precision oncology must evolve to address health disparities

June 04, 2021
Vol.47 No.22
By Brandon Mahal and Jeffrey Venstrom
Cheryl Willman named head of Mayo Clinic Cancer Programs, director of cancer center
Conversation with The Cancer Letter

Cheryl Willman named head of Mayo Clinic Cancer Programs, director of cancer center

May 21, 2021
Vol.47 No.20
By Paul Goldberg
“1001cuts”—A GYN oncologist examines the toll of sexism in the OR
Conversation with The Cancer LetterFilm & TV

“1001cuts”—A GYN oncologist examines the toll of sexism in the OR

May 14, 2021
Vol.47 No.19
By Alexandria Carolan
What we can do: Responding to hate crimes and racially motivated violence against Asians, Pacific Islanders
EditorialHealth Disparities

What we can do: Responding to hate crimes and racially motivated violence against Asians, Pacific Islanders

April 02, 2021
Vol.47 No.13
By Matthew Bin Han Ong, Alexandria Carolan, Katie Goldberg and Paul Goldberg

Posts navigation

Previous1…2829

Trending Stories

  • Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
  • Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
  • Pam Bondi diagnosed with thyroid cancer
  • The story of daraxonrasib is the ultimate hero’s journey
    A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe
  • As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon
  • At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account